Eli Lilly has not said why it is seeing this shortage The shortage will only affect vials of insulin, not the pens, which doctors hope will help alleviate some of the panic people may be experiencing.

When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously ...

After years of preparation, Eli Lilly is on the brink of launching ... The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a recently-approved Smart Button device ...

Two years ago, Eli Lilly started working with Dexcom ... app-based remote monitoring and alarm functions – in pen- and pump-based insulin systems that form the basis of the drugmaker’s ...

Objective: To assess the functionality and patient acceptability of HumaPen Ergo ®, a new 3.0ml reusable insulin pen. Design: Patients trialled HumaPen Ergo ® (Eli Lilly) over 5 to 7 weeks and ...

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

In 2023, the global disposable pen injectors market is expected to be worth USD 25.5 billion. The market is expected to reach USD 54.4 billion by 2033, expanding at a 7.9% CAGR throughout the forecast ...

Since their introduction in 1985, insulin pens have become increasingly sophisticated. Pens are available in 2 different forms, with either replaceable cartridges or disposable prefilled cartridges.

The official spokesperson for the Ministry of Health and Population Hossam Abdel-Ghaffar announced details on the extended-release for the first locally produced batch of insulin “Glargine ...